208.04
-8.06 (-3.73%)
| Penutupan Terdahulu | 216.10 |
| Buka | 211.02 |
| Jumlah Dagangan | 2,156,496 |
| Purata Dagangan (3B) | 1,158,830 |
| Modal Pasaran | 29,010,993,152 |
| Harga / Jualan (P/S) | 11.69 |
| Harga / Buku (P/B) | 16.32 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Keuntungan | -10.36% |
| Margin Operasi (TTM) | -15.78% |
| EPS Cair (TTM) | -1.47 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 36.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.78% |
| Nisbah Semasa (MRQ) | 3.87 |
| Aliran Tunai Operasi (OCF TTM) | 153.12 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 120.93 M |
| Pulangan Atas Aset (ROA TTM) | -8.87% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Natera, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.70 |
|
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier’s children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 3.24% |
| % Dimiliki oleh Institusi | 96.37% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Duquesne Family Office Llc | 31 Dec 2025 | 2,511,357 |
| Castle Hook Partners Lp | 31 Dec 2025 | 2,167,869 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 300.00 (Citigroup, 44.20%) | Beli |
| Median | 260.00 (24.98%) | |
| Rendah | 215.00 (Wells Fargo, 3.35%) | Pegang |
| Purata | 263.00 (26.42%) | |
| Jumlah | 8 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 223.93 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 03 Mar 2026 | 250.00 (20.17%) | Beli | 207.04 |
| Baird | 27 Feb 2026 | 257.00 (23.53%) | Beli | 208.04 |
| Evercore ISI Group | 27 Feb 2026 | 260.00 (24.98%) | Beli | 208.04 |
| Wells Fargo | 27 Feb 2026 | 215.00 (3.35%) | Pegang | 208.04 |
| 15 Dec 2025 | 205.00 (-1.46%) | Pegang | 228.40 | |
| Citigroup | 07 Jan 2026 | 300.00 (44.20%) | Beli | 254.40 |
| Guggenheim | 05 Jan 2026 | 270.00 (29.78%) | Beli | 237.42 |
| Canaccord Genuity | 22 Dec 2025 | 285.00 (36.99%) | Beli | 235.57 |
| Barclays | 15 Dec 2025 | 270.00 (29.78%) | Beli | 228.40 |
| JP Morgan | 15 Dec 2025 | 260.00 (24.98%) | Beli | 228.40 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BROPHY MICHAEL BURKES | 208.04 | - | 10,051 | 2,091,010 |
| CHAPMAN STEVEN LEONARD | 208.04 | 200.17 | 33,451 | 6,990,233 |
| FESKO JOHN | 208.04 | - | 10,051 | 2,091,010 |
| MOSHKEVICH SOLOMON | 208.04 | 200.17 | 7,051 | 1,490,500 |
| RABINOWITZ DANIEL | 208.04 | - | 12,272 | 2,553,067 |
| RABINOWITZ MATTHEW | 208.04 | - | 29,920 | 6,224,557 |
| SHEENA JONATHAN | 208.04 | 200.17 | -967 | -177,014 |
| Jumlah Keseluruhan Kuantiti Bersih | 101,829 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 21,263,363 | |||
| Purata Pembelian Keseluruhan ($) | 208.04 | |||
| Purata Jualan Keseluruhan ($) | 200.17 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CHAPMAN STEVEN LEONARD | Pegawai | 02 Mar 2026 | Jual automatik (-) | 3,950 | 200.17 | 790,672 |
| MOSHKEVICH SOLOMON | Pegawai | 02 Mar 2026 | Jual automatik (-) | 3,000 | 200.17 | 600,510 |
| MOSHKEVICH SOLOMON | Pegawai | 02 Mar 2026 | Pelaksanaan pilihan | 5,125 | - | - |
| SHEENA JONATHAN | Pengarah | 02 Mar 2026 | Jual automatik (-) | 3,070 | 200.17 | 614,522 |
| FESKO JOHN | Pegawai | 27 Feb 2026 | Diperolehi (+) | 10,051 | 208.04 | 2,091,010 |
| BROPHY MICHAEL BURKES | Pegawai | 27 Feb 2026 | Diperolehi (+) | 10,051 | 208.04 | 2,091,010 |
| RABINOWITZ MATTHEW | Pegawai | 27 Feb 2026 | Diperolehi (+) | 29,920 | 208.04 | 6,224,557 |
| RABINOWITZ DANIEL | Pegawai | 27 Feb 2026 | Diperolehi (+) | 12,272 | 208.04 | 2,553,067 |
| CHAPMAN STEVEN LEONARD | Pegawai | 27 Feb 2026 | Diperolehi (+) | 37,401 | 208.04 | 7,780,904 |
| MOSHKEVICH SOLOMON | Pegawai | 27 Feb 2026 | Diperolehi (+) | 10,051 | 208.04 | 2,091,010 |
| SHEENA JONATHAN | Pengarah | 27 Feb 2026 | Diperolehi (+) | 2,103 | 208.04 | 437,508 |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |